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ABSTRACT: Background: Recent studies support
the therapeutic utility of repetitive transcranial magnetic
stimulation in Parkinson’s disease (PD), whose progres-
sion is correlated with loss of corticostriatal long-term
potentiation and long-term depression. Glial cell activa-
tion is also a feature of PD that is gaining increasing
attention in the field because astrocytes play a role in
chronic neuroinflammatory responses but are also able
to manage dopamine (DA) levels.
Methods: Intermittent theta-burst stimulation protocol
was applied to study the effect of therapeutic neuromo-
dulation on striatal DA levels measured by means of in
vivo microdialysis in 6-hydroxydopamine-hemilesioned
rats. Effects on corticostriatal synaptic plasticity were
studied through in vitro intracellular and whole-cell
patch clamp recordings while stepping test and Cat-
Walk were used to test motor behavior. Immunohisto-
chemical analyses were performed to analyze
morphological changes in neurons and glial cells.
Results: Acute theta-burst stimulation induced an
increase in striatal DA levels in hemiparkinsonian rats,
80 minutes post-treatment, correlated with full recovery
of plasticity and amelioration of motor performances.
With the same timing, immediate early gene activation
was restricted to striatal spiny neurons. Intense astro-
cytic and microglial responses were also significantly
reduced 80 minutes following theta-burst stimulation.
Conclusion: Taken together, these results provide a first
glimpse on physiological adaptations that occur in the
parkinsonian striatum following intermittent theta-burst
stimulation and may help to disclose the real potential of
this technique in treating PD and preventing DA replace-
ment therapy-associated disturbances. VC 2017 Interna-
tional Parkinson and Movement Disorder Society
Key Words: Parkinson’s disease; corticostriatal syn-
aptic plasticity; transcranial magnetic stimulation; glia;
long-term potentiation
In Parkinson’s disease (PD), altered dopamine (DA)
receptor stimulation exerts its main effect in the stria-
tum, producing changes in input integration, imbalance
between direct and indirect striatofugal pathways, and
dysfunctional changes in basal ganglia output. As the
disease advances, neuronal degeneration also pro-
gresses, leading to the emergence of symptoms refracto-
ry to conventional therapy.
Increasing evidence suggests a strong relationship
between inflammation and nigrostriatal degeneration
based on the enhanced vulnerability of nigral neurons
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to oxidative stress, which leads to production of reac-
tive oxygen species, lipid peroxidation, mitochondrial
alterations, and neuronal dysfunction.1 The resulting
propagation of neuroinflammatory responses perpetu-
ates a feed-forward cycle and is considered causative
of PD progression.2,3 In such a scenario, DA replace-
ment therapy, although it initially alleviates motor
symptoms, may bring (lead) to incapability to further
respond to neuronal damage and promote cell prolif-
eration and survival.
Repetitive transcranial magnetic stimulation (rTMS)
is a noninvasive neuromodulatory technique that
allows functional recovery in disease conditions char-
acterized by aberrant forms of synaptic plasticity.4
Using theta-burst stimulation (TBS), a specific rTMS
pattern, high-frequency bursts of stimuli are delivered
at low intensity over cortical areas and produce long-
lasting inhibitory or facilitatory effects, when continu-
ous (cTBS) or intermittent (iTBS) modes are used,
respectively.5 The results from clinical studies on the
efficacy of TBS in treating PD symptoms are mixed,
and no conclusive opinion has been reached so far
except for the common evidence that PD patients lack
the typical TMS-induced responses.6,7 In experimental
settings, TBS has different effects in modifying protein
expression8 and the activity of inhibitory interneur-
ons.9 However, neither clinical nor experimental stud-
ies have been done in the control condition or PD
state to address the specific effect of TBS on cortico-
striatal plasticity, which is considered an optimal para-
digm to study PD-associated synaptic and behavioral
alterations.10 In PD loss of nigrostriatal terminals,
releasing DA is correlated with overt motor symptoms
and impairment in the induction of DA-dependent
corticostriatal plasticity, that is, long-term potentiation
(LTP) and mechanisms of scaling down such as depot-
entiation and long-term depression (LTD).10,11 An
interesting feature of rTMS is the ability to induce DA
release in the caudate nucleus12 and increases in serum
DA levels in untreated parkinsonian patients following
stimulation.13 Similarly, in experimental animals, cor-
tical rTMS is able to induce DA release in subcortical
regions14 and, in particular, increases the DA content
of the dorsolateral striatum.15
Based on this evidence, we explored the hypothesis
that cortical iTBS may help residual dopaminergic net-
works to overcome effects of toxic insult, contain neu-
roinflammation, and rescue striatal plasticity and
function in a 6-hydroxydopamine (6-OHDA)-lesioned
model of PD.
Methods
Extended methods may be found in the supplemen-
tary data file.
Unilateral 6-OHDA Lesion
Male Wistar rats (n5135) for behavior and electro-
physiology were deeply anesthetized and unilaterally
injected with saline (sham-operated, control (CTRL)
n555) or 6-OHDA (6-OHDA-lesioned, n5 80) into the
medial forebrain bundle as previously reported16 (Fig. 1a).
Theta-Burst Stimulation
Sham-operated and 6-OHDA-lesioned rats were sub-
jected to a single iTBS session as previously
described17 with minor modifications.
Motor Behavior Assessment
The stepping test was used as previously reported.18
Every animal was tested before and 20 or 80 minutes
after the exposure to iTBS. Quantitative assessment of
gait was obtained in both CTRL and 6-OHDA-
lesioned prior to stimulation and 80 minutes after the
iTBS session using an automated analysis system Cat-
Walk XT (Noldus Information Technology).19
Microdialysis
Rats were anesthetized, mounted in a stereotaxic
frame, and implanted with a nonmetal disposable
guide cannula (outer diameter of 0.38 mm, length
4 mm) in the striatum ipsilateral to the 6-OHDA-
lesioned side (anteroposterior (AP)523.6; mediolat-
eral (ML)511.84). Dialysates were collected in
awake animals and analyzed as previously
reported.20,21
Electrophysiology
Animals receiving sham or real iTBS were divided
into two groups, with one sacrificed 20 minutes post-
iTBS the other sacrificed 80 minutes post-iTBS. Corti-
costriatal coronal slices were prepared, and glutama-
tergic excitatory postsynaptic potentials (EPSPs) were
evoked in intracellular and whole-cell patch clamp
recordings as previously described.16,22 LTP and LTD
were induced through a high-frequency stimulation
(HFS) protocol in magnesium-free and in a physiologi-
cal medium, respectively.23,24
Immunohistochemistry and Confocal Analysis
Rats were fully anesthetized for perfusion.25 The sec-
tions were selected and incubated overnight at 4 8C in
phosphate buffer (PB) containing 0.3% Triton X-100
and 1% bovine serum albumin (BSA) with primary anti-
bodies then incubated with a cocktail of secondary anti-
bodies as previously described.25 To assess lesion,
sections including the substantia nigra (SN) and ventral
tegmental area were selected and incubated overnight at
4 8C with a primary antibody rabbit anti-tyrosine
hydroxylase (1:500), then with a secondary antibody
Alexa Fluor 555 (Thermo Fisher Scientific) donkey
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antirabbit (1:200; Supporting Fig. S1). Confocal image
acquisitions and analysis were performed as previously
described using a confocal laser-scanning microscope
(Zeiss CLSM700, ZEISS Germany). For each section, 2
digital squared frames (area50.1 mm2) of 6 rostro-
caudally spaced sections were examined.
Statistics
Statistics were performed using Prism 6.0 (GraphPad
Software, Inc). Group comparisons were analyzed
with 1- or 2-way analysis of variance and with Bonfer-
roni or uncorrected Fisher least significant difference
FIG. 1.
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post hoc tests. Values given in the text and in the fig-
ures are mean6 standard error of the mean. A paired
Student t test was used to compare pre- versus post-
HFS protocol in the same cell. An alpha level of .05
was used.
Results
Acute iTBS Changes DA Levels in Dorsolateral
Striatum With a Specific Temporal Pattern
As extracellular DA levels in both the cortical and
subcortical areas seem to be modulated by TMS,26,27
changes in striatal DA outflow after a single iTBS ses-
sion were measured by in vivo microdialysis in awake
6-OHDA-lesioned (n57) and CTRL (n5 7) rats
habituated to a moderate restraint (Fig. 1b, inset).
DA levels in the CTRL rats were slightly above pre-
iTBS levels with a fast and transient decrease to 220%
of baseline occurring 80 minutes after stimulation. At
the same time, 6-OHDA-lesioned rats showed a peak of
DA of approximately 40% above pre-stimulation base-
line while its mean level throughout the other fractions
was 15% below, with a negative peak at 20 minutes.
Significant difference was found 20 (P< .05) and 80
minutes post-treatment (P< .01; Fig. 1b).
iTBS Improves Gait and Akinesia
To assess changes in the organization of gait in 6-
OHDA-lesioned and the effects of iTBS, the CatWalk
test was used. Although habituated to the experimen-
tal setting, hemiparkinsonian rats showed slowness of
movements and difficulty in walking through the Cat-
Walk corridor because of their tendency to manifest
turning behavior. Therefore, among the variables
extracted from the automated analysis, we focused on
the regularity index, a sensitive indicator of interpaw
coordination.19
When subjected to CatWalk trials, hemiparkinso-
nian rats (n5 9) showed a reduced rate of normal step
sequence patterns when compared with the CTRL rats
(n55; Fig. 1c; P< .001). An effect on the regularity
index was found in lesioned rats 80-minutes post-
iTBS. Although a net difference between pre- and
post-iTBS was not reached in the 6-OHDA-lesioned
rats, the coordination was more similar between the
iTBS-treated groups.
To test the impact of iTBS on asymmetry and fore-
limb akinesia, a first group of 8 hemilesioned animals
was subjected to a stepping test 20 minutes post-stim-
ulation. Although a slight improvement in the
impaired forelimb use after iTBS can be noticed (Fig.
1d, left panel; P< .001 pre-iTBS comparisons between
ipsilateral and contralateral limbs; P< .01 post-iTBS,
n5 7), no statistical difference was found between
left/right ratio pre- and post-iTBS treatment. This
effect was a result of the iTBS-induced general
increase of locomotion, significant in ipsilateral limbs
(P< .05), which failed to return any significant effect
on asymmetry improvement.
A group of 7 hemiparkinsonian animals were tested
80 minutes post-iTBS (Fig. 1d, center panel) and dis-
played a significant improvement in the impaired fore-
limb use (P< .05), with a difference in left/right ratio
forelimb use (P< .001, n56). Overall, the therapeutic
effects of iTBS appeared to be time dependent: hemi-
parkinsonian animals, whose motor activity was tested
80 minutes post-iTBS, showed a higher number of
adjusting steps with the impaired forelimb compared
to 6-OHDA-lesioned tested 20 minutes after stimula-
tion (Fig. 1d, right panel; P< .01).
FIG. 1. The intermittent theta-burst stimulation (iTBS) driven dopamine boost affects motor coordination. a: Experimental planning. Animals were
subjected to an apomorphine-induced rotation test 2 weeks after receiving intracerebral 6-hydroxydopamine (6-OHDA) or saline. After 6 weeks, the
animals were exposed to a single iTBS session and then underwent behavioral tests, electrophysiological recordings, and morphological analyses
20 or 80 minutes after stimulation. b: Time course of in vivo microdialysis performed in dorsolateral striatum showing average DA levels expressed
in percentage relative to baseline values (dotted line). Dialysates were collected every 10 minutes starting 1 hour before iTBS application. A time-
3 treatment interaction was found (2-way analysis of variance: interaction, F9,10853.49, P<.001), pointing to an overall difference in their time
courses. Statistical difference between the 2 groups (n5 7 for both) was revealed 20 (uncorrected Fisher’s least significant difference post hoc test,
*P<.05) and 80 minutes (**P<.01) after stimulation. c: Histograms showing averaged normal step sequence patterns relative to total number of paw
placement calculated as regularity index using CatWalk automated analysis of gait, 80 minutes after iTBS. Although stimulation did not alter the nor-
mal step sequence patterns of healthy animals (n5 5), DA-depleted animals showed a significant impairment of interpaw coordination (n59; 1-way
analysis of variance: interaction, F3,64511.41, P<.001; 6-OHDA pre-iTBS vs control (CTRL) pre-iTBS: Bonferroni post hoc, ***P<.001). Acute iTBS
treatment did not affect motor activity in CTRL while improving interpaw coordination in lesioned rats, displaying performances similar to healthy
controls (6-OHDA 80 minutes iTBS vs CTRL 80 minutes post-iTBS: Bonferroni post hoc, P>.05). d: Histograms showing mean number of adjusting
forelimb steps during stepping test in 6-OHDA-lesioned animals prior to iTBS and 20 (n5 7) or 80 minutes (n56) later. Left panel: Cortical iTBS
induced a general increase of locomotion in both limbs ipsilateral and contralateral to lesion side, but failed to return any significant effect on asym-
metry improvement when measured 20 minutes after stimulation (paired Student t test, pre-iTBS, ipsilateral (Ipsi) vs contralateral (Contra): t65 7.99,
***P<.001; post-iTBS, Ipsi vs Contra: t65 5.94, **P<.01; Ipsi, pre-iTBS vs post-iTBS: t653.32, #P<.05). No statistical difference was found between
left/right ratio pre- and post-iTBS treatment (unpaired Student t test, Ipsi/Contra pre-iTBS vs Ipsi/Contra post-iTBS: t1451, P>.05). Middle panel:
Graph showing a significant improvement in the impaired forelimb (contralateral) use was found at 80 minutes (paired Student t test, pre-iTBS, Ipsi
vs Contra post hoc, ***P<.001; post-iTBS, Ipsi vs Contra **P<.01; Contra, pre-iTBS vs post-iTBS: t553.73, #P<.05). At this time point, a statistical
difference in left/right ratio forelimb use was found (unpaired Student t test, Ipsi/Contra pre-iTBS vs Ipsi/Contra post-iTBS: t105 5.31, ***P<.001).
Right panel: Histogram of the time dependence of iTBS effects on the impaired forelimb use resulting in a higher number of adjusting steps per-
formed 80 minutes after stimulation (unpaired Student t test, Contra 20 minutes post-iTBS vs Contra 80 minutes post-iTBS: t1153.46, **P<.01).
[Color figure can be viewed at wileyonlinelibrary.com]
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No significant effect of iTBS was observed in the
CTRL groups (20 minutes post-iTBS, n55; 80
minutes post-iTBS, n5 5; data not shown). For the
stepping test, 1 animal per group was discarded for
behavioral alterations during the pre-TMS session that
prevented the accomplishment of procedures.
Corticostriatal LTD, but not LTP, Is Rescued
20 Minutes After iTBS
The effects of iTBS were evaluated comparing neurons
recorded from 28 6-OHDA-lesioned rats 20 minutes post
real or sham-iTBS and from and 18 CTRL rats exposed
to real iTBS. In standard artificial CerebroSpinal Fluid
(aCSF), firing rate, firing pattern, and current-voltage
relationships showed no differences among groups (Fig.
2a). As expected, HFS of corticostriatal fibers failed to
induce LTD in striatal projection neurons (SPNs) of 6-
OHDA-lesioned exposed to sham-iTBS (n512). In con-
trast, acute iTBS was able to restore this form of plasticity
in the majority of neurons recorded from 6-OHDA-
lesioned rats (n5 12). In rats exposed to iTBS, once
induced, the time course of LTD was similar between 6-
OHDA and CTRL (Fig. 2b, upper panel).
The ability to induce LTP in a Mg21-free medium was
then tested. In this condition, HFS of corticostriatal
fibers induced a LTP in iTBS-treated CTRL rats. Con-
versely, most of the corticostriatal SPNs recorded from
6-OHDA-lesioned rats exposed to sham-iTBS failed to
show long-term changes. Acute iTBS induced in SPNs a
potentiation that did not last over time (n510), with
EPSP amplitudes rapidly decreasing to baseline levels
(Fig. 2b, lower panel). Baseline EPSPs properties were
unchanged by prior exposure to iTBS (Fig. 2b, left,
gray). The effects of iTBS on corticostriatal plasticity are
summarized in Figures 2c and 2d.
LTD and LTP Are Both Completely Restored
80 Minutes After iTBS
By shifting the sacrifice to 80 minutes post-iTBS, we
were able to investigate the effects on corticostriatal
FIG. 2. Corticostriatal synaptic plasticity changes occurring 20 minutes after intermittent theta-burst stimulation (iTBS) stimulation. a, upper panel: Repre-
sentative current-voltage (I/V) traces of CTRL 20 minutes post-iTBS, 6-hydroxydopamine (6-OHDA)1sham-iTBS and 6-OHDA 20 minutes post-iTBS
obtained from striatal projection neurons. Lower panel: Graph showing I/V relationships in the 3 groups. b, upper panel: Time course of excitatory postsyn-
aptic potential (EPSP) amplitude of spiny projection neurons (SPNs) from control (CTRL) exposed to iTBS (n512) and 6-OHDA-lesioned rats exposed to
either sham or real iTBS (n5 12 each group) expressed in percentage of pre-high frequency stimulation (HFS) baseline, measured before and after appli-
cation of the long-term depression (LTD) protocol. On the right, representative traces of EPSP prior to HFS (gray line) and 30 minutes after HFS (different
color per group) are shown. Scale factor is 20 ms/5 mV for all traces. Orange arrow represents HFS protocol. Two-way analysis of variance: interaction,
F36,5945 12.01, P<.001; 6-OHDA 20 minutes post-iTBS (n512) versus 6-OHDA1sham-iTBS (n5 12), 30 minutes after HFS: Bonferroni post hoc,
***P<.001. Lower panel: Time course of EPSP amplitude of SPNs from CTRL exposed to iTBS (n511) and 6-OHDA-lesioned rats exposed to either sham
or real iTBS (n511 and n510, respectively) after induction of long-term potentiation (LTP) protocol and representative traces prior to HFS (gray line) and
30 minutes after HFS (different color per group). Two-way analysis of variance: interaction, F36,46857.35, P<.001; 6-OHDA 20 minutes post-iTBS (n5 10)
versus 6-OHDA1sham-iTBS (n511): Bonferroni post hoc, P>.05 30 minutes post-HFS. c: Histogram showing EPSP amplitude 30 minutes post-HFS
after LTD protocol (CTRL 20 minutes post-iTBS vs 6-OHDA1sham-iTBS, ***P<.001; 6-OHDA 20 minutes post-iTBS vs 6-OHDA1sham-iTBS, ***P<.001).
d: Histogram of EPSP amplitude 30 minutes post HFS after LTP protocol (CTRL 20 minutes post-iTBS vs 6-OHDA1sham-iTBS, ***P<.001; 6-OHDA 20
minutes post-iTBS vs 6-OHDA1sham-iTBS, P>.05). [Color figure can be viewed at wileyonlinelibrary.com]
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plasticity of 11 6-OHDA-lesioned rats and 8 CTRL
rats at a time point corresponding to the DA peak
revealed by microdialysis measurements. At this time,
intrinsic membrane properties were found unaffected
(Fig. 3a). Similarly, LTD appeared to be restored in
6-OHDA-lesioned rats exposed to iTBS when com-
pared with animals subjected to sham-iTBS (n512,
P< .001). Both LTD induction and maintenance were
not influenced by the DA peak as there was no statis-
tical difference between 6-OHDA rats 80 minutes
post-iTBS and CTRL rats 80 minutes post-iTBS (Fig.
3b, upper panel). Conversely, in the SPNs of hemile-
sioned rats, the ability to induce and maintain cortico-
striatal LTP was fully recovered by iTBS (Fig. 3b,
lower panel; n5 11, P< .001). Similar to the protocol
at 20 minutes, baseline EPSP properties appeared
unchanged by iTBS when tested 80 minutes post-iTBS
(Fig. 3b, gray). Changes in corticostriatal plasticity
expressed in percentages are summarized in Figure 3c
and d.
c-Fos Is Selectively Activated in Spiny
Neurons After iTBS
Qualitative and quantitative changes of c-Fos activa-
tion after iTBS were analyzed in the motor cortex,
dorsal striatum, SN, and motor thalamus of lesioned
(n515) and CTRL rats (n515) by confocal micros-
copy techniques (12 samples/rat; n5 5 animals/group).
In the sham-iTBS-exposed CTRL group, in all brain
areas analyzed, c-Fos immunostaining pattern was
characterized by a widespread and faint cellular
immunopositivity with some scant c-Fos1/DARPP-
321 cells (data not shown). After 20 minutes and 80
minutes post-iTBS, no significant changes were
observed in the motor cortex, SN, or thalamus (data
not shown) or in the dorsolateral striatum (Fig. 4a,c)
compared to sham-iTBS. In the striatum of 6-OHDA
rats exposed to sham-iTBS, the c-Fos expression pat-
tern (Fig. 4a) and the total number of c-Fos1 cells
were not significantly different when compared with
the CTRL rats (Fig. 4c, upper panel). When
FIG. 3. Corticostriatal synaptic plasticity changes occurring 80 minutes after intermittent theta-burst stimulation (iTBS). a, upper panel: Representa-
tive I/V traces of CTRL 80 minutes post-iTBS, 6-hydroxydopamine (6-OHDA)1sham-iTBS and 6-OHDA 80 minutes post-iTBS obtained from striatal
projection neurons. Lower panel: Graph showing I/V relationships of the 3 groups. b, upper panel: Time course of excitatory postsynaptic potential
(EPSP) amplitude expressed in percentage of pre-high frequency stimulation (HFS) baseline after application of the long-term depression (LTD) pro-
tocol. On the right, representative traces of EPSP prior to HFS (gray line) and 30 minutes after HFS (different color per group) are shown. Scale fac-
tor is 20 ms/5 mV for all traces. Orange arrow represents the application of HFS protocol. Two-way analysis of variance: interaction, F36,594515.22,
P<.001; 6-OHDA 80 minutes post-iTBS (n5 12) vs 6-OHDA1sham-iTBS (n5 12): Bonferroni post hoc, ***P<.001 30 minutes post-HFS. Lower pan-
el: Time course of EPSP amplitude expressed in percentage of pre-HFS baseline in long-term potentiation (LTP) protocol and representative traces.
Treated 6-OHDA rats recover a physiological LTP 80 minutes after iTBS. Two-way analysis of variance: interaction, F36,4865 4.35, P<.001; 6-OHDA
80 minutes post-iTBS (n511) versus 6-OHDA1sham-iTBS (n5 11): Bonferroni post hoc, **P<.001 30 minutes post-HFS. c: Histogram showing
comparison of EPSP amplitude 30 minutes post-HFS in LTD protocol (CTRL 80 minutes post-iTBS [n512] vs 6-OHDA1sham-iTBS, ***P<.001; 6-
OHDA 80 minutes post-iTBS vs 6-OHDA1sham-iTBS, ***P<.001). d: Histogram showing mean percentage of EPSP amplitude 30 minutes post-HFS
in LTP protocol (CTRL 80 minutes post-iTBS [n511] vs 6-OHDA1sham-iTBS, ***P<.001; 6-OHDA 80 minutes post-iTBS vs 6-OHDA1sham-iTBS,
***P<.001). [Color figure can be viewed at wileyonlinelibrary.com]
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hemiparkinsonian animals were exposed to iTBS and
sacrificed 20 minutes later, a slight increase of total
number of c-Fos1 cells was found in the striatum
(Fig. 4c, upper panel). However, by shifting the sacri-
fice to 80 minutes, we observed a significant effect on
striatal c-Fos activation (Fig. 4c, upper panel;
P< .001). Double immunofluorescence of c-Fos and
DARPP-32 confirmed that c-Fos was mainly expressed
by striatal SPNs (Fig. 4c, lower panel; P< .001). To
determine the specificity of this effect, the double
labeling of c-Fos and choline acetyltransferase or par-
valbumin was performed showing lack of c-Fos activa-
tion (Fig. 4b). Furthermore, this effect was exclusively
restricted to the striatum as c-Fos expression was not
enhanced in the motor cortex, SN, or thalamus (Sup-
porting Fig. S2).
iTBS Reduces Astrogliosis and Microglial
Activation
To characterize the effects of TMS treatment on
glial responses induced by 6-OHDA lesion, astrocytes
and microglia were analyzed by confocal microscopy
(12 samples/rat; n55 animals/group). In sham-iTBS
treated CTRL rats, the number of Glial Fibrillary,
Acidic, Protein (GFAP)1 astrocytes and of ionized
calcium binding adaptor molecule 1 (Iba-1) 1
microglial cells was very low (data not shown). At 20
or 80 minutes post-iTBS, the total number of
GFAP1 astrocytes and of Iba-11microglial cells were
not changed in the CTRL groups subjected to stimula-
tion (Fig. 5b). An intense astrocytic response was
observed in the striatum ipsilateral to the lesion
(Fig. 5a). In 6-OHDA1sham-iTBS animals, many
densely stained and hypertrophic GFAP1 cells with
long and ramified processes were found (Fig. 5b, upper
panel; P< .001). Similarly, a great number of Iba-
11 activated microglial cells was found (Fig. 5b, lower
panel; P< .001). When sacrificed 20 minutes post-iTBS,
a slight, but not significant, decrease of the total num-
ber of GFAP1 and Iba-11 cells was observed (Fig.
5a,b). By shifting the sacrifice to 80 minutes, a signifi-
cant reduction of the total number of GFAP1 and Iba-
11 cells (Fig. 5a,b) compared to all conditions was
found (P< .001).
Discussion
With this study, we bring evidence of the possible
role of glial cells in mediating the TMS-dependent
recovery of striatal functions in experimental parkin-
sonism. Acute exposure to iTBS protocol caused an
increase in striatal levels of DA, ipsilateral to 6-
OHDA lesion, at a specific time point corresponding
to 80 minutes after stimulation. Concurrently, the
ability to express DA-dependent bidirectional plastici-
ty, recorded in SPNs, was recovered and associated
with a significant increase in region- and cell type-
specific c-Fos immunoreactivity. Behavioral correlates
were a major decrease of forelimb akinesia and
improvement of gait, supporting the idea that a rescue
of corticostriatal plasticity may underlie recovery of
motor control. A restoration of plasticity was associat-
ed with widespread effects in the dorsolateral stria-
tum, showing marked reduction of both astrogliosis
and abnormal microglia activation.
In PD therapy, the use of rTMS has considerably
increased during the past decade owing to the evi-
dence that neurostimulation can induce DA release in
the caudate nucleus of healthy subjects when elicited
on prefrontal28 and motor cortical areas.12 Based on
these clinical findings and on the observation that
rTMS is able to induce DA release in subcortical
regions of experimental animals,14,15,26 we asked
whether iTBS, a protocol known to induce long-
lasting activation of cortical areas,29 could overcome
the effects of denervation and rescue a physiological
synaptic activity by reorganizing cortico-subcortical
networks. We previously demonstrated that 20
minutes after a single session of iTBS, a moderate
recovery of corticostriatal LTD, which is lost in the
PD condition, was associated with a net increase of
excitability in all of the striatal neuronal populations,
measured as excitatory postsynaptic field potentials
through extracellular recordings.17 This first observa-
tion provided the basis for exploring the hypothesis
that a rearrangement of cortical networks together
with increased striatal DA levels could possibly recov-
er corticostriatal plasticity at a single cell level.
Here, we explored the time dependence of iTBS
effects on parkinsonism and linked the increase in
striatal DA levels produced by iTBS to the rescue of
bidirectional corticostriatal plasticity and striatal func-
tions. To measure DA variations, we employed intra-
cerebral guide cannulas and probes compatible with
magnetic field that allow in vivo microdialysis meas-
urements with minimal tissue damage. Previous work
showing TMS-induced changes in DA levels and
release were performed in healthy animals using differ-
ent patterns of stimulation.15 Although in our model
rats show nearly full lesion, which could possibly have
made it difficult to detect striatal DA, we could moni-
tor DA concentration changes in the dorsolateral stria-
tum after iTBS exposure. Notably, most of the
animals displayed a distinctive and consistent time
course characterized by a peak around 80 minutes
post-stimulation.
To find a behavioral correlate of these changes, we
used two tests that provided motor activity informa-
tion rapidly and, shortly after, prepared the brains for
electrophysiological and immunohistochemical analy-
ses within the same time point. At 20 minutes, little or
no effect of iTBS was observed in counteracting the
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FIG. 4. A single session of intermittent theta-burst stimulation (iTBS) induces c-Fos activation in the striatum of 6-hydroxydopamine (6-OHDA) fully
lesioned animals 80 minutes after treatment. a: Confocal images from dorsolateral striatum ipsilateral to the lesion side (schematic representation of
the positioning on the upper right side) obtained from sham-operated (CTRL) 20 minutes and 80 minutes post-iTBS, 6-OHDA1sham-iTBS and 6-
OHDA animals 20 minutes and 80 minutes post-iTBS (12 samples per rat, n5 5 animals per group). c-Fos is shown in red, dopamine- and cAMP-
regulated neuronal phosphoprotein (DARPP-32) in green, and 40,6-Diamidine-20-phenylindole dihydrochloride (DAPI) in gray. In both CTRL condi-
tions, only some c-Fos1 cells colocalized with DARPP-32 (upper panels). In 6-OHDA animals, a slight increment in the number of colocalizing cells
is visible (middle panel) as well as in 6-OHDA 20 minutes post-iTBS (4th panel). 6-OHDA 80 minutes post-iTBS animals showed a great number of
c-Fos positive cells. Double immunofluorescence of c-Fos and DARPP-32 confirmed that c-Fos was mainly expressed by DARPP-32 medium spiny
neurons (5th panel). Scale bars: 50 mm. b: Confocal images of c-Fos and choline acetyltransferase (ChAT) immunostaining in the ipsilateral striatum
of 6-OHDA animals 80 minutes post-iTBS (upper panel) showed a lack of localization of c- Fos in cholinergic interneurons. Confocal images of c-
Fos and parvalbumin (PV) immunostaining (lower panel) showed a lack of localization in parvalbumin-positive interneurons. Scale bars: 25 mm. c:
Representative histogram of the total number of c-Fos positive cells (upper panel) and of the percentage of c-Fos1neurons colocalizing with
DARPP-32 (lower panel). The 6-OHDA 80 minutes post-iTBS rats showed a marked increase in both total number of c-Fos1 cells (1-way analysis
of variance: treatment effect, F4,205 60.81, P<.001; 6-OHDA 80 minutes post-iTBS vs 6-OHDA1sham-iTBS and 6-OHDA 20 minutes post-iTBS:
Bonferroni post hoc, ***P<.001) and DARPP-32 colocalization (1-way analysis of variance: treatment effect, F4,20526.28, P<.001; 6-OHDA 80
minutes post-iTBS vs all other groups: Bonferroni post hoc, ***P<.001). [Color figure can be viewed at wileyonlinelibrary.com]
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FIG. 5. Acute intermittent theta-burst stimulation (iTBS) reduces glial activation in the striatum of 6-hydroxydopamine (6-OHDA) fully lesioned ani-
mals 80 minutes after treatment. a: Confocal images from the ipsilateral striatum (dorso-lateral) of sham-operated (CTRL) 20 minutes and 80 minutes
post-iTBS, 6-OHDA1sham-iTBS and 6-OHDA animals 20 minutes and 80 minutes post-iTBS reacted with Glial fibrillary acidic protein (GFAP) (green)
and ionized calcium binding adaptor molecule 1 (Iba-1) (red) and counterstained with 40,6-Diamidine-20-phenylindole dihydrochloride (DAPI) (blue) to
elucidate astrocytes (GFAP) and microglial (Iba-1) responses to iTBS (12 samples per rat, n55 animals per group). iTBS treated sham-operated ani-
mals show little glial activation (upper panels). A state of neuroinflammation is evident in 6-OHDA animals, as expected (middle panel), and is still
ongoing 20 minutes post-iTBS (4th panel). A striking reduction of neuroinflammation, in the form of a diminished number of both astrocytes and
microglial cells, happened in 6-OHDA 80 minutes post-iTBS animals (bottom panel). Scale bars: 50 mm. b: Histogram of the total number of GFAP
positive (upper panel) and Iba-1 positive cells (lower panel) in all groups. Data are reported as means6 standard error of the mean. The 6-
OHDA1sham-iTBS animals show a very high astrocytic (1-way analysis of variance: treatment effect, F5,24591.26, P<.001) and microglial (1-way
analysis of variance: treatment effect, F5,24546.46, P<.001) activation, compared to sham-operated animals (vs CTRL 20 minutes and 80 minutes
post-iTBS: Bonferroni post hoc, ***P<.001). Inflammation is greatly reduced in 6-OHDA 80 minutes post-iTBS rats as both the number of
GFAP1 cells and of Iba-11 cells are reduced (GFAP1 vs 6-OHDA1sham-iTBS: Bonferroni post hoc, ***P<.001; Iba-11 vs 6-OHDA1sham-iTBS:
Bonferroni post hoc, ***P<.001). [Color figure can be viewed at wileyonlinelibrary.com]
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forelimb akinesia and asymmetry that are typically
related to unilateral 6-OHDA lesion. A general
increase of motor activity was observed in both paws
in lesioned and sham-operated rats, according to the
excitatory effect that this protocol exerts on motor
cortical areas. However, when motor behavior was
tested 80 minutes after a single iTBS session, a net
beneficial effect was observed, resulting in similar limb
use between ipsilateral and contralateral paws. In
addition, gait abnormalities, consisting of a significant
decrease in the regularity index, were attenuated 80
minutes after iTBS treatment in hemiparkisonian rats,
which showed more organized step sequence patterns,
resembling sham-operated rats.
From these data three basic questions emerged. The
first asked if the increase in striatal DA was sufficient
to rescue corticostriatal plasticity and function, the
second dealt with the cell-type specificity of this
response, and the third was related to the possible
mechanisms underlying the therapeutic effects.
To address the first question, electrophysiological
analysis was performed in SPNs by means of intracel-
lular and patch-clamp recordings. Impairment in the
induction of the two forms of corticostriatal plasticity,
LTD and LTP, has been found to correlate with DA
depletion and the onset of symptoms in experimental
parkinsonism. In early PD, DA depletion initially does
not affect LTD, but turns LTP into a form of short-
term plasticity.18 Later, when symptoms are fully
manifested, both LTD and LTP are impaired. In our
experiments, iTBS rescues both forms of synaptic plas-
ticity in a temporal dynamic that reflects DA levels
changes, suggesting that compensative mechanisms
allowing LTP resurgence may depend on DA mecha-
nisms more than that required by LTD. It is notewor-
thy that the time course of DA changes in response to
TMS was different in the CTRL animals. A possible
explanation is that in sham-operated animals, DA
increase may rely on intact nigrostriatal terminals. In
the parkinsonian condition, where the terminals are
functionally absent, we suppose that an alternative
source of DA may be engaged. Interestingly, after 20
minutes LTD is recovered, but such a return of func-
tion was not sufficient to allow a full recovery of LTP,
providing a pattern of alterations similar to what
observed in partially lesioned animals, modeling early
symptomatic PD.18 This effect can be explained by the
evidence that the induction of LTD depends on the
activation of both D1 and D2 dopaminergic receptors,
the latter being more sensitive to low levels of DA
when compared with D1. However, coincident with a
recovery of LTD at 20 minutes, a trough in DA levels
was found. This finding seems to suggest that this
effect may not depend on DA because this form of
plasticity is under control of additional mechanisms,
recruiting interneurons, and other signaling
pathways30,31 all aimed at the preservation of SPNs
activity and integrity. We therefore cannot rule out
the possibility that an early compensative response of
striatal circuitry allowing LTD recovery may recruit
non-DA mechanisms. On this line, it has been
reported that iTBS is able to induce long-term changes
in the expression of activity-dependent proteins of the
cortical inhibitory interneurons8 and in particular in
the neuronal activity of inhibitory interneurons.32
Such selective activation of neuronal subtypes suggests
that distinct TMS patterns can differentially affect spe-
cific neuronal populations.
To gain further insights into possible cell-type specific
effects of iTBS in the dorsolateral striatum, electrophysi-
ology was paralleled by the immunohistochemical char-
acterization of c-Fos expression in the principal
populations of striatal cells in 6-OHDA-lesioned rats. A
modest increase of c-Fos immunoreactivity was found
selectively in DARPP-32-expressing SPNs 20 minutes
post-stimulation. When the experiments were replicated
80 minutes post-iTBS, the expression of corticostriatal
LTP was fully recovered in the hemiparkinsonian rats.
At the same time, c-Fos expression was greatly enhanced
and the effect was restricted to DARPP-32-expressing
neurons with no signal detected in interneurons. Concur-
rent analysis in the SN pars reticulata, motor thalamus,
and motor cortex returned no changes in the early gene
expression, clearly suggesting that iTBS has a cell type–
specific and region-specific effect, coincident with the
area in which DA increase was observed. In future stud-
ies it would be informative to analyze how this compen-
sative changes vary with time by measuring c-Fos
expression at different time points after TMS. Further
discussion on this point may be found in the supplemen-
tary data file.
Such a selective effect despite an extensive stimula-
tion points to the translational relevance of our
results. In fact, it is possible that iTBS, by increasing
DA in a particularly vulnerable but highly responsive
area, thus restoring plasticity and motor control, may
open a therapeutically relevant window in which func-
tional and structural changes may reorganize the abili-
ty of striatal microcircuit to manage DA levels.
To test this hypothesis and to address the third
question we studied two cellular populations that pro-
vide an indispensable support to neuronal activity by
modulating DA and glutamate levels thus influencing
synaptic plasticity: astrocytes and microglia. Recent
evidence points to the ability of TMS to modulate the
activity of glial cells, which have extensive connectivi-
ty and cell type–specific ability to directly or indirectly
respond to neuronal firing, making them optimal can-
didates for mediating widespread TMS effects.33
Immunohistochemical analysis shows that in 6-
OHDA-lesioned rats, neurodegeneration progresses
with time as a marked astrocytosis and microglial
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activation was strikingly visible two months after the
lesion in the striatal samples. iTBS, as early as 20
minutes post-treatment, was able to reduce GFAP and
Iba-1 immunoreactivity, but the greatest effect was
found at 80 minutes, when the signal of both markers
was lowered to control levels. These data are consis-
tent with several studies recently reviewed by Cullen
and Young,33 demonstrating abnormal microglia acti-
vation in postmortem samples from PD patients and
in experimental parkinsonism.34-37 Microglia is impli-
cated in the production of neurotrophins, interleu-
kines, and proinflammatory and antiinflammatory
citokines34-37 that, if dysregulated, may contribute to
abnormal plasticity. Also the finding of astrocytic
changes in shape and functions in association with DA
levels is supported by studies demonstrating that these
cells in critical conditions release DA and express
enzymes and the complete machinery to metabolize
it.38-40 Moreover, relevant to PD, astrocytes can man-
age striatal DA levels, working as a reservoir for circu-
lating levodopa.41
On this view, a different time course in sham- versus
6-OHDA-lesioned rats might reflect different mecha-
nisms (synaptic vs nonsynaptic) by which DA levels
change in response to TMS. Taken together, these
data suggest that glial cells may have a role in iTBS
effects on corticostriatal plasticity. Our results, if con-
firmed in PD patients, might be relevant in a therapeu-
tic framework. Such intrinsic potential of the striatal
synapse to implement the management of endogenous
DA may offer an optimized response to DA-
replacement therapies or to noninvasive therapeutic
neuromodulation techniques.
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